How Biotech Startups Are Cashing In on AI Drug Discovery

The Series A Show with Fexingo: Early-Stage Funding, Pitch Decks, and Startup Milestones · May 22, 2026 · 7m · transcript

Lucas and Luna dive into the biotech startup boom fueled by AI drug discovery. With the ARKG Genomics ETF surging over 10% in the past five days, they examine how early-stage biotech startups are leveraging artificial intelligence to slash drug development timelines and costs. Lucas breaks down the typical funding stages for an AI biotech startup, from seed to Series A, and highlights a key metric investors look for: preclinical validation. Luna questions whether the hype is outpacing the science, pointing to the recent volatility in the sector. They discuss real examples like Recursion…